These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10583884)

  • 1. Epitope-specific glutamic acid decarboxylase-65 autoantibodies in intravenous immunoglobulin preparations.
    Hao W; Davis C; Daniels T; Hampe CS; Lernmark A
    Transfus Med; 1999 Dec; 9(4):307-10. PubMed ID: 10583884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of autoantibody epitopes of glutamic acid decarboxylase in stiff-man syndrome patients.
    Li L; Hagopian WA; Brashear HR; Daniels T; Lernmark A
    J Immunol; 1994 Jan; 152(2):930-4. PubMed ID: 7506741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.
    Kim J; Namchuk M; Bugawan T; Fu Q; Jaffe M; Shi Y; Aanstoot HJ; Turck CW; Erlich H; Lennon V; Baekkeskov S
    J Exp Med; 1994 Aug; 180(2):595-606. PubMed ID: 7519242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders.
    Powers AC; Bavik K; Tremble J; Daw K; Scherbaum WA; Banga JP
    Clin Exp Immunol; 1999 Dec; 118(3):349-56. PubMed ID: 10594551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct antigenic features of linear epitopes at the N-terminus and C-terminus of 65 kDa glutamic acid decarboxylase (GAD65): implications for autoantigen modification during pathogenesis.
    Al-Bukhari TA; Radford PM; Bouras G; Davenport C; Trigwell SM; Bottazzo GF; Lai M; Schwartz HL; Tighe PJ; Todd I
    Clin Exp Immunol; 2002 Oct; 130(1):131-9. PubMed ID: 12296864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome.
    Dinkel K; Meinck HM; Jury KM; Karges W; Richter W
    Ann Neurol; 1998 Aug; 44(2):194-201. PubMed ID: 9708541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus.
    Walikonis JE; Lennon VA
    Mayo Clin Proc; 1998 Dec; 73(12):1161-6. PubMed ID: 9868413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients.
    Raju R; Foote J; Banga JP; Hall TR; Padoa CJ; Dalakas MC; Ortqvist E; Hampe CS
    J Immunol; 2005 Dec; 175(11):7755-62. PubMed ID: 16301686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes.
    Hampe CS; Hammerle LP; Bekris L; Ortqvist E; Kockum I; Rolandsson O; Landin-Olsson M; Törn C; Persson B; Lernmark A
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4671-9. PubMed ID: 11134126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two amino acids in glutamic acid decarboxylase act in concert for maintenance of conformational determinants recognised by Type I diabetic autoantibodies.
    Tree TI; Morgenthaler NG; Duhindan N; Hicks KE; Madec AM; Scherbaum WA; Banga JP
    Diabetologia; 2000 Jul; 43(7):881-9. PubMed ID: 10952461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
    Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine monoclonal glutamic acid decarboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and stiff-man syndrome.
    Ziegler B; Schlosser M; Lühder F; Strebelow M; Augstein P; Northemann W; Powers AC; Ziegler M
    Acta Diabetol; 1996 Sep; 33(3):225-31. PubMed ID: 8904930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM.
    Falorni A; Ackefors M; Carlberg C; Daniels T; Persson B; Robertson J; Lernmark A
    Diabetologia; 1996 Sep; 39(9):1091-8. PubMed ID: 8877294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope-restricted 65-kilodalton glutamic acid decarboxylase autoantibodies among new-onset Sardinian type 2 diabetes patients define phenotypes of autoimmune diabetes.
    Maioli M; Alejandro E; Tonolo G; Gilliam LK; Bekris L; Hampe CS; Obinu DA; Manconi A; Puddu L; Lynch K; Lernmark A;
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5675-82. PubMed ID: 15531528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A diabetes-related epitope of GAD65: a major diabetes-related conformational epitope on GAD65.
    Myers MA; Fenalti G; Gray R; Scealy M; Tong JC; El-Kabbani O; Rowley MJ
    Ann N Y Acad Sci; 2003 Nov; 1005():250-2. PubMed ID: 14679070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusion proteins for combined analysis of autoantibodies to the 65-kDa isoform of glutamic acid decarboxylase and islet antigen-2 in insulin-dependent diabetes mellitus.
    Rickert M; Seissler J; Dangel W; Lorenz H; Richter W
    Clin Chem; 2001 May; 47(5):926-34. PubMed ID: 11325898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes.
    Schlosser M; Banga JP; Madec AM; Binder KA; Strebelow M; Rjasanowski I; Wassmuth R; Gilliam LK; Luo D; Hampe CS
    Diabetologia; 2005 May; 48(5):922-30. PubMed ID: 15834701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoassay for glutamic acid decarboxylase-65.
    Hao W; Daniels T; Pipeleers DG; Smismans A; Reijonen H; Nepom GT; Lernmark A
    Diabetes Technol Ther; 1999; 1(1):13-20. PubMed ID: 11475299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous methylprednisolone or immunoglobulin for anti-glutamic acid decarboxylase 65 antibody autoimmune encephalitis: which is better?
    Li TR; Zhang YD; Wang Q; Shao XQ; Li ZM; Lv RJ
    BMC Neurosci; 2020 Mar; 21(1):13. PubMed ID: 32228575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of human monoclonal autoantibodies to glutamic acid decarboxylase.
    Hayakawa N; Premawardhana LD; Powell M; Masuda M; Arnold C; Sanders J; Evans M; Chen S; Jaume JC; Baekkeskov S; Smith BR; Furmaniak J
    Autoimmunity; 2002 Aug; 35(5):343-55. PubMed ID: 12515289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.